BEIJING SL PHARMAC financial statements, including revenue, expenses, profit, and loss

The total revenue of 002038 for the last quarter is 243.52 M CNY, and it's 2.05% higher compared to the previous quarter. The net income of Q1 24 is 70.13 M CNY.